Search research articles
Contact Us
Filters
Showing results (101-110 of 110) with videos related to
Page
of 11
Sort By:
You have reached the last page of results.
This site can display upto 110 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 29, 2000
Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazine, N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiforme
V A Levin, J H Uhm, K A Jaeckle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 10, 1999
Phase II study of phenylacetate in patients with recurrent malignant glioma: a North American Brain Tumor Consortium report
S M Chang, J G Kuhn, H I Robins, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 13, 2001
Phase III trial of accelerated hyperfractionation with or without difluromethylornithine (DFMO) versus standard fractionated radiotherapy with or without DFMO for newly diagnosed patients with glioblastoma multiforme
M D Prados, W M Wara, P K Sneed, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 17, 1998
Phase I study of paclitaxel in patients with recurrent malignant glioma: a North American Brain Tumor Consortium report
S M Chang, J G Kuhn, J Rizzo, et al.
Pediatric Neurosurgery
|
June 1, 1996
Long-term follow-up after high-activity 125I brachytherapy for pediatric brain tumors
P K Sneed, C Russo, C O Scharfen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 24, 1999
Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group
W K Yung, M D Prados, R Yaya-Tur, et al.
Journal of Neurosurgery
|
October 10, 1997
Serial proton magnetic resonance spectroscopy imaging of glioblastoma multiforme after brachytherapy
L L Wald, S J Nelson, M R Day, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 11, 1998
Survival benefit of hyperthermia in a prospective randomized trial of brachytherapy boost +/- hyperthermia for glioblastoma multiforme
P K Sneed, P R Stauffer, M W McDermott, et al.
British Journal of Cancer
|
August 17, 2000
A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse
W K Yung, R E Albright, J Olson, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 9, 1998
Radiation therapy and hydroxyurea followed by the combination of 6-thioguanine and BCNU for the treatment of primary malignant brain tumors
M D Prados, D A Larson, K Lamborn, et al.
Page
of 11
Search research articles
Search
Showing results (101-110 of 110) with videos related to
Sort By:
Page
of 11
You have reached the last page of results.
This site can display upto 110 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 29, 2000
Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazine, N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiforme
V A Levin, J H Uhm, K A Jaeckle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 10, 1999
Phase II study of phenylacetate in patients with recurrent malignant glioma: a North American Brain Tumor Consortium report
S M Chang, J G Kuhn, H I Robins, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 13, 2001
Phase III trial of accelerated hyperfractionation with or without difluromethylornithine (DFMO) versus standard fractionated radiotherapy with or without DFMO for newly diagnosed patients with glioblastoma multiforme
M D Prados, W M Wara, P K Sneed, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 17, 1998
Phase I study of paclitaxel in patients with recurrent malignant glioma: a North American Brain Tumor Consortium report
S M Chang, J G Kuhn, J Rizzo, et al.
Pediatric Neurosurgery
|
June 1, 1996
Long-term follow-up after high-activity 125I brachytherapy for pediatric brain tumors
P K Sneed, C Russo, C O Scharfen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 24, 1999
Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group
W K Yung, M D Prados, R Yaya-Tur, et al.
Journal of Neurosurgery
|
October 10, 1997
Serial proton magnetic resonance spectroscopy imaging of glioblastoma multiforme after brachytherapy
L L Wald, S J Nelson, M R Day, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 11, 1998
Survival benefit of hyperthermia in a prospective randomized trial of brachytherapy boost +/- hyperthermia for glioblastoma multiforme
P K Sneed, P R Stauffer, M W McDermott, et al.
British Journal of Cancer
|
August 17, 2000
A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse
W K Yung, R E Albright, J Olson, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 9, 1998
Radiation therapy and hydroxyurea followed by the combination of 6-thioguanine and BCNU for the treatment of primary malignant brain tumors
M D Prados, D A Larson, K Lamborn, et al.
Page
of 11